Table 2.
Chest Computed Tomography (CT) findings of COVID-19 patients
| Location | Number (%) |
|---|---|
| Right upper lobe | |
| Apical | 24 (38.1) |
| Posterior | 35 (55.5) |
| Anterior | 23 (36.5) |
| Right middle lobe | |
| Lateral | 41 (65.1) |
| Medial | 11 (17.5) |
| Right lower lobe | |
| Superior | 49 (77.8) |
| Posterior | 47 (74.6) |
| Medial | 40 (63.5) |
| Anterior | 26 (41.3) |
| Lateral | 45 (71.4) |
| Left upper lobe | |
| Apicoposterior | 22 (34.9) |
| Anterior | 24 (38.1) |
| Superior lingula | 26 (41.2) |
| Inferior lingula | 25 (39.7) |
| Left lower lobe | |
| Superior | 39 (61.9) |
| Anteromedial | 22 (34.9) |
| Lateral | 48 (76.2) |
| Posterior | 52 (82.5) |
| Imaging Characteristics | |
| Bilateral | 53 (84.1) |
| Peripheral GGO | 58 (92.1) |
| Consolidation | 27 (42.9) |
| Peri-bronchovascular GGO | 13 (20.6) |
| Sub pleural band | 6 (9.5) |
| Interlobular septal thickening | 4 (6.3) |
| Pleural effusion | 1 (1.5) |
| GGO severity | |
| Mild | 32 (50.7) |
| Moderate | 20 (31.7) |
| Severe | 11 (17.4) |
GGO: ground-glass opacification.